Technical.ly: A new cell therapy center aims to strengthen Baltimore’s position in ‘DNA Valley’

Johns Hopkins Medicine and biotech company Orgenesis are partnering to launch the Maryland Center for Cell Therapy Manufacturing, supported by a $5 million matching grant from the State of Maryland.

The facility will close the loop on the biotech ecosystem in Maryland while allowing for lab and patient trials to be done in Baltimore instead of outsourced to another city, like Boston or Philadelphia, which would keep dollars flowing inside the city instead of leaving it.

Read the full article at Technical.ly